AUG 13, 2026 · JOURNAL ARTICLE
Insulin Resistance in Polyendocrine Metabolic Ovarian Syndrome: Mechanisms, Clinical Evidence, and Emerging Biomarkers
International Journal of Medical & Pharmaceutical Sciences
A narrative review synthesizing case-control and cross-sectional evidence that replicates established understanding of insulin resistance as central to PMOS pathophysiology, without new interventional trials or practice-level guidance.
Important Confirmatory EvidenceI. Kavipriya*1, K. Malarvizhi2, J. Karthi3, S. Swarnalatha4Ovarian Function and Disorders
Reported
Indian PMOS prevalence range2.2% to 26%